While under myelosuppressive (chemo-)therapy, growth factors, such as G-CSF, should be given according to the guidelines of the American Society of Clinical Oncology.71 The use of G-CSF also might benefit patients who experience prolonged cytopenias after treatment with alemtuzumab.